Astrana Health
ASTH
133 hedge funds and large institutions have $731M invested in Astrana Health in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 13 closing their positions.
5,412% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $211K
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
28% more capital invested
Capital invested by funds: $571M → $731M (+$160M)
3% more funds holding
Funds holding: 129 → 133 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 46
7.44% less ownership
Funds ownership: 42.32% → 34.88% (-7.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.6M |
| 2 |
NAM
NorthCrest Asset Manangement
Plymouth,
Minnesota
|
+$7M |
| 3 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
+$5.1M |
| 4 |
SW
SteelPeak Wealth
Woodland Hills,
California
|
+$1.82M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$7.74M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.23M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.56M |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$1.4M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.31M |
ASTH Hedge Fund Activity: Q1 2023 in Review
133 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q1 2023, worth a combined $731M — up 28% from $571M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ASTH positions and 13 closed out — a net gain of 5 holders — while 44 added to existing stakes and 46 trimmed.
The largest buyer was Vanguard Group, adding an estimated $9.6M. The largest seller was BlackRock, cutting an estimated $7.74M.
- 133 institutional investors held Astrana Health (ASTH) as of Q1 2023, up from 129 in Q4 2022.
- Funds reported $731M of Astrana Health stock for Q1 2023, up 28% quarter-over-quarter.
- 18 funds opened new Astrana Health positions in Q1 2023 and 13 closed out, a net change of +5 holders.
- The largest Astrana Health buyer in Q1 2023 was Vanguard Group, an estimated $9.6M added.
- The largest Astrana Health seller in Q1 2023 was BlackRock, an estimated $7.74M sold.
Based on aggregated 13F filings for Q1 2023.